Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
FEMS Microbiol Rev ; 46(5)2022 10 28.
Article in English | MEDLINE | ID: mdl-35675280

ABSTRACT

Interference with public good cooperation provides a promising novel antimicrobial strategy since social evolution theory predicts that resistant mutants will be counter-selected if they share the public benefits of their resistance with sensitive cells in the population. Although this hypothesis is supported by a limited number of pioneering studies, an extensive body of more fundamental work on social evolution describes a multitude of mechanisms and conditions that can stabilize public behaviour, thus potentially allowing resistant mutants to thrive. In this paper we theorize on how these different mechanisms can influence the evolution of resistance against public good inhibitors. Based hereon, we propose an innovative 5-step screening strategy to identify novel evolution-proof public good inhibitors, which involves a systematic evaluation of the exploitability of public goods under the most relevant experimental conditions, as well as a careful assessment of the most optimal way to interfere with their action. Overall, this opinion paper is aimed to contribute to long-term solutions to fight bacterial infections.


Subject(s)
Biological Evolution , Social Evolution , Research
2.
Cell Rep ; 38(7): 110372, 2022 02 15.
Article in English | MEDLINE | ID: mdl-35172131

ABSTRACT

The Pseudomonas quinolone signal (PQS) is a multifunctional quorum sensing molecule of key importance to P. aeruginosa. Here, we report that the lytic Pseudomonas bacterial virus LUZ19 targets this population density-dependent signaling system by expressing quorum sensing targeting protein (Qst) early during infection. We demonstrate that Qst interacts with PqsD, a key host quinolone signal biosynthesis pathway enzyme, resulting in decreased levels of PQS and its precursor 2-heptyl-4(1H)-quinolone. The lack of a functional PqsD enzyme impairs LUZ19 infection but is restored by external supplementation of 2-heptyl-4(1H)-quinolone, suggesting that LUZ19 exploits the PQS system for successful infection. We establish a broad functional interaction network of Qst, which includes enzymes of cofactor biosynthesis pathways (CoaC/ThiD) and a non-ribosomal peptide synthetase pathway (PA1217). Qst therefore represents an exquisite example of intricate reprogramming of the bacterium by a phage, which may be further exploited as tool to combat antibiotic resistant bacterial pathogens.


Subject(s)
Bacteriophages/metabolism , Pseudomonas aeruginosa/metabolism , Quorum Sensing , Acetyltransferases/metabolism , Anti-Bacterial Agents/metabolism , Bacterial Proteins/metabolism , Carbon/metabolism , Metabolic Networks and Pathways , Metabolome , Metabolomics , Models, Biological , Pseudomonas aeruginosa/growth & development , Pseudomonas aeruginosa/virology , Quinolones/metabolism , Secondary Metabolism , Viral Proteins/metabolism
3.
Nat Commun ; 11(1): 107, 2020 01 09.
Article in English | MEDLINE | ID: mdl-31919364

ABSTRACT

Bacteria commonly form dense biofilms encased in extracellular polymeric substances (EPS). Biofilms are often extremely tolerant to antimicrobials but their reliance on shared EPS may also be a weakness as social evolution theory predicts that inhibiting shared traits can select against resistance. Here we show that EPS of Salmonella biofilms is a cooperative trait whose benefit is shared among cells, and that EPS inhibition reduces both cell attachment and antimicrobial tolerance. We then compare an EPS inhibitor to conventional antimicrobials in an evolutionary experiment. While resistance against conventional antimicrobials rapidly evolves, we see no evolution of resistance to EPS inhibition. We further show that a resistant strain is outcompeted by a susceptible strain under EPS inhibitor treatment, explaining why resistance does not evolve. Our work suggests that targeting cooperative traits is a viable solution to the problem of antimicrobial resistance.


Subject(s)
Anti-Bacterial Agents/pharmacology , Biofilms/growth & development , Extracellular Polymeric Substance Matrix/metabolism , Imidazoles/pharmacology , Salmonella typhimurium/growth & development , Drug Resistance, Bacterial/genetics , Drug Resistance, Bacterial/physiology , Extracellular Polymeric Substance Matrix/drug effects , Salmonella typhimurium/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...